Skip to main content

Peer Review reports

From: Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures

Original Submission
3 Mar 2021 Submitted Original manuscript
1 Jun 2021 Reviewed Reviewer Report - William Cragg
7 Jun 2021 Reviewed Reviewer Report - Anastasia Karachalia-Sandri Karachalia-Sandri
8 Jul 2021 Author responded Author comments - Silke van Koningsbruggen-Rietschel
Resubmission - Version 2
8 Jul 2021 Submitted Manuscript version 2
Publishing
12 Jul 2021 Editorially accepted
28 Aug 2021 Article published 10.1186/s13063-021-05457-5

You can find further information about peer review here.

Back to article page